Racial disparity in treatment of osteoporosis after diagnosis
Racial disparity in treatment of osteoporosis after diagnosis
复制标题
DOI：
10.1007/s00198-006-0178-y
复制
发表时间：
2006-11-01
影响因子：
4
通讯作者：
Cummings, D. M.
中科院分区：
文献类型：
--
作者：
Hamrick, I.;Whetstone, L. M.;Cummings, D. M.
在临床医学的一些领域已经确定了种族差异。诊断为骨质疏松症的患者应接受类似的治疗，无论种族如何。然而，有限的数据是可用的相对频率治疗后，诊断为osteoporosis.Methods的种族，我们分析了所有739双能X线吸收测定（DXA）的结果，获得的妇女50岁及以上，1998年至2002年在我们的医疗中心。我们的研究样本是82%的白人和15%的非洲裔美国人。353名妇女谁有低骨密度的第一DXA，我们抽象的电子和纸质病历比较治疗率的race.Results诊断为骨质疏松症或骨量减少的妇女，80.0%和68.3%，分别开始抗吸收药物。在非裔美国妇女中，61.9%的诊断为骨质疏松的妇女开始接受抗骨吸收治疗，而白人妇女为83.3%（p
Introduction Racial disparities have been identified in a number of areas in clinical medicine. Patients diagnosed with osteoporosis should be treated similarly regardless of race. However, limited data are available on the relative frequency of treatment by race after diagnosis of osteoporosis.Methods We analyzed all 739 dual-energy X-ray absorptiometry (DXA) results obtained of women 50 years old and older between 1998 and 2002 at our medical center. Our study sample was 82% Caucasian and 15% African American. Of 353 women who had low bone mineral density on first DXA, we abstracted the electronic and paper medical records to compare treatment rates by race.Results Of the women diagnosed with osteoporosis or osteopenia, 80.0% and 68.3%, respectively, were started on antiresorptive medications. Of the African American women, 61.9% diagnosed with osteoporosis were started on antiresorptive treatment compared with 83.3% of Caucasian women (p